Senestech Stock Today

SNES Stock  USD 2.15  0.22  9.28%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Risky

 
High
 
Low
SenesTech is selling for under 2.15 as of the 24th of February 2026; that is 9.28 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.08. SenesTech has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 26th of November 2025 and ending today, the 24th of February 2026. Click here to learn more.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona. Senestech operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. The company has 5.22 M outstanding shares of which 36.09 K shares are at this time shorted by private and institutional investors with about 0.83 trading days to cover. More on SenesTech

Moving against SenesTech Stock

  0.8SFZN Siegfried HoldingPairCorr
  0.67VTYX Ventyx BiosciencesPairCorr
  0.64CVG CSPC PharmaceuticalPairCorr
  0.63ELAN Elanco Animal Health Earnings Call TomorrowPairCorr
  0.61RHO6 Roche HoldingPairCorr
  0.59DYF1 Dynavax TechnologiesPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

SenesTech Stock Highlights

President CEOJoel Fruendt
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Basic Materials, Nasdaq Industrial, NASDAQ Composite, Health Care, Pharmaceuticals, Specialty Chemicals, Basic Materials (View all Sectors)
Financial Strength
SenesTech (SNES) is traded on NASDAQ Exchange in USA and employs 23 people. SenesTech is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.38 M. SenesTech conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 5.22 M outstanding shares of which 36.09 K shares are at this time shorted by private and institutional investors with about 0.83 trading days to cover. SenesTech currently holds about 5.02 M in cash with (6.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Check SenesTech Probability Of Bankruptcy
Ownership Allocation
The market capitalization of SenesTech is $12.38 Million. SenesTech has 4.21 % of its outstanding shares held by insiders and 26.78 % owned by institutional holders. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check SenesTech Ownership Details

SenesTech Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. SenesTech market risk premium is the additional return an investor will receive from holding SenesTech long position in a well-diversified portfolio.

SenesTech Stock Against Markets

SenesTech Corporate Management

Jamie JDInterim ChairProfile
Steven KrauseEx MarketingProfile
Michael EdellInterim OfficerProfile
Bryan MennaVice SalesProfile
Paul PalzVP ControllerProfile

Additional Tools for SenesTech Stock Analysis

When running SenesTech's price analysis, check to measure SenesTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenesTech is operating at the current time. Most of SenesTech's value examination focuses on studying past and present price action to predict the probability of SenesTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenesTech's price. Additionally, you may evaluate how the addition of SenesTech to your portfolios can decrease your overall portfolio volatility.